Capital Advisors Ltd’s Repligen RGEN Stock Holding History

Capital Advisors Ltd’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	1	–	–	﹤0.01%	1550
2026 Q1	$0	Hold	1	–	–	﹤0.01%	1563
2025 Q4	$0	Hold	1	–	–	﹤0.01%	1536
2025 Q3	$0	Hold	1	–	–	﹤0.01%	1527
2025 Q2	$0	Buy	+1	New	+$127	﹤0.01%	1588
2024 Q3	–	Sell	-3	Closed	–	–	1572
2024 Q2	$0	Buy	+3	New	+$470	﹤0.01%	1602
2023 Q4	–	Sell	-2	Closed	–	–	1454
2023 Q3	$0	Buy	+2	New	+$327	﹤0.01%	1448
2023 Q2	–	Sell	-13	Closed	-$2K	–	1504
2023 Q1	$2K	Hold	13	–	–	﹤0.01%	927
2022 Q4	$2K	Sell	13 -7	-35%	-$1.27K	﹤0.01%	893
2022 Q3	$4K	Buy	20 +7	+54%	+$1.48K	﹤0.01%	698
2022 Q2	$2K	Buy	13 +9	+225%	+$1.42K	﹤0.01%	690
2022 Q1	$1K	Buy	4 +3	+300%	+$570	﹤0.01%	788
2021 Q4	$0	Buy	+1	New	+$269	﹤0.01%	916

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Capital Advisors Ltd's RGEN Position: Q2 2026 in Review

Capital Advisors Ltd held its Repligen (RGEN) position steady in Q2 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1550.

Capital Advisors Ltd first reported a position in RGEN in Q4 2021 and has held it in 13 quarters since. The position peaked at $4K in Q3 2022. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Capital Advisors Ltd held 1 share of Repligen worth $0 as of Q2 2026.
Capital Advisors Ltd left its Repligen share count unchanged in Q2 2026.
Repligen made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1550 holding.
Capital Advisors Ltd first reported a position in Repligen in Q4 2021 and has held it in 13 quarters since.
Capital Advisors Ltd's Repligen position peaked at $4K in Q3 2022.
482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.